Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06880679 · ClinicalTrials.gov registry record · NA
Ultrasound Acute Chest Syndrome Sickle Cell Disease
A NA study of Sickle Cell Disease and Acute Chest Syndrome, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06880679: Recruiting NA study of Sickle Cell Disease and Acute Chest Syndrome, sponsored by Indiana University.
NCT06880679 is a NA study of Sickle Cell Disease and Acute Chest Syndrome that is actively recruiting participants, run by Indiana University. The registered enrollment target is 30 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06880679, a NA study of Sickle Cell Disease and Acute Chest Syndrome, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Feasibility and reliability of ultrasound in the inpatient hematology setting.
Primary Outcome
Percentage of patients who are approached for study who agree to be on study
Conditions Studied
Interventions
- DEVICE Point of Care Ultrasound
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-04-08 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What NCT06880679 shows while recruiting
NCT06880679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Point of Care Ultrasound is the first listed.
NCT06880679 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06880679 about?
NCT06880679 is a clinical study titled "Ultrasound Acute Chest Syndrome Sickle Cell Disease". Feasibility and reliability of ultrasound in the inpatient hematology setting.
What is the current status of trial NCT06880679?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-04-08. Estimated completion is 2026-03-01.
What conditions does trial NCT06880679 study?
This clinical trial studies the following conditions: Sickle Cell Disease, Acute Chest Syndrome.
What interventions are being tested in trial NCT06880679?
The interventions under investigation include: Point of Care Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT06880679?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06880679 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06880679's enrollment target sits among peer trials
30 139th of 213 higher than 67 of 213 other Sickle Cell Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sickle Cell Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Cutaneous Hydration Assessment in SCD
RECRUITING · NA
-
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI